Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Declared position

51.68%

Threshold

Crossed downwards

Timeline

Published

23.02.2021

Transaction

15.02.2021

Voting rights breakdown

Voting rights acquired9.91%
Voting rights sold51.68%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAL2I00032

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

regarding certain sales positions

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open